Stiolto Respimat 2.736 ug/1

Stiolto Respimat 2.736 ug/1 is a combination inhaler containing tiotropium bromide and olodaterol. It is used for managing chronic obstructive pulmonary disease (COPD) symptoms. This metered spray helps improve breathing and reduce airway inflammation.

Stiolto Respimat 2.736 ug/1 is primarily used for the maintenance treatment of chronic obstructive pulmonary disease (COPD). It combines tiotropium bromide, a long-acting anticholinergic, and olodaterol, a long-acting beta-agonist, to help open airways and improve breathing. This medication is often prescribed for individuals with COPD to manage symptoms such as wheezing, shortness of breath, and coughing. It is not intended for immediate relief of sudden breathing problems.

Common effects of Stiolto Respimat 2.736 ug/1 may include dry mouth, throat irritation, and coughing after use. Some users might experience headaches, dizziness, or muscle cramps. These effects are generally mild and temporary. If any severe or persistent effects occur, it is important to consult a healthcare provider.

Stiolto Respimat 2.736 ug/1 should be used as directed by a healthcare professional. It is important to follow the prescribed dosage and administration instructions. This medication should not be used to treat sudden breathing problems or asthma attacks. Individuals with certain medical conditions, such as heart disease or severe allergies, should discuss their health status with their healthcare provider before using this inhaler.

Stiolto Respimat 2.736 ug/1 may interact with other medications, including beta-blockers, anticholinergics, and certain antidepressants. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Additionally, this inhaler should be used with caution in individuals who are sensitive to its active ingredients or any of its inactive components.